Yuen Y. Wong

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Apoptosis protein markers in comorbid type 2 diabetes mellitus and depression; relationships with cognitive performance, incident dementia, and white matter hyperintensities.

Apoptosis protein markers in comorbid type 2 diabetes mellitus and depression; relationships with cognitive performance, incident dementia, and white matter hyperintensities.

Journal: Journal of affective disorders

Published: March 23, 2026

Cognitive and Neuroanatomical Effects of Fatty Acid Amide Hydrolase Polymorphism rs324420 in Aging and Alzheimer Disease.

Cognitive and Neuroanatomical Effects of Fatty Acid Amide Hydrolase Polymorphism rs324420 in Aging and Alzheimer Disease.

Journal: Alzheimer disease and associated disorders

Published: January 29, 2026

Type 2 Diabetes Mellitus, Cognitive Performance, and Incident Dementia; Identifying Mediating Pathways and Biomarkers From the Plasma Proteome.

Type 2 Diabetes Mellitus, Cognitive Performance, and Incident Dementia; Identifying Mediating Pathways and Biomarkers From the Plasma Proteome.

Journal: Journal of neurochemistry

Published: August 26, 2025

Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase-derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance.

Metabolic and vascular contributions to dementia: Soluble epoxide hydrolase-derived linoleic acid oxylipins and glycemic status are related to cerebral small vessel disease markers, atrophy, and cognitive performance.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 25, 2025

Change in Cognition Following Ischaemic Stroke.

Change in Cognition Following Ischaemic Stroke.

Journal: Annals of clinical and translational neurology

Published: April 18, 2025

Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes.

Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes.

Journal: Molecular psychiatry

Published: January 25, 2024

Tenth-anniversary Glasgow Neuro Society 2022 conference proceedings.

Tenth-anniversary Glasgow Neuro Society 2022 conference proceedings.

Journal: Surgical neurology international

Published: August 03, 2023

Sex differences in associations between APOE ε2 and longitudinal cognitive decline.

Sex differences in associations between APOE ε2 and longitudinal cognitive decline.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: November 22, 2022

IgG4-Related Sclerosing Disease of the Temporal Bone: A Systematic Review.

IgG4-Related Sclerosing Disease of the Temporal Bone: A Systematic Review.

Journal: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology

Published: August 08, 2022

Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis.

Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis.

Journal: Parkinsonism & related disorders

Published: March 09, 2022

Early Metazoan Origin and Multiple Losses of a Novel Clade of RIM Presynaptic Calcium Channel Scaffolding Protein Homologs.

Early Metazoan Origin and Multiple Losses of a Novel Clade of RIM Presynaptic Calcium Channel Scaffolding Protein Homologs.

Journal: Genome biology and evolution

Published: May 11, 2020

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status.

Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 05, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026